Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
70 participants
INTERVENTIONAL
2015-07-31
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Taking into account these considerations, the aim of the investigators' study is to determine the effectiveness, in terms of ongoing pregnancy rates, to advance the intrauterine insemination with sperm donor (24 hours post-hCG) with respect to the standard schedule (36 hours post-hCG) according progesterone levels determined the day of hCG administration
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interest of Sperm Insemination at 42 Hours Post hCG Compared to 36h in Intrauterine Insemination
NCT06804538
Observation of the Response to Ovulation Triggering on the Day of Intrauterine Insemination and Correlation Between Progesterone Level and Pregnancy Rate (OVUL-IIU)
NCT07038616
Luteal Phase Progesterone in IUI and Gonadotropin Cycles
NCT01941875
HCG Versus Spontaneous LH in Intrauterine Insemination (IUI ) Cycles
NCT01414673
Timing of Intrauterine Insemination (IUI) 24 or 48 Hours After Spontaneous Luteinizing Hormone (LH) Peak
NCT01622023
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The influence of progesterone levels in stimulated cycles of intrauterine insemination is an aspect little studied; however, this information can be useful when synchronizing the time of insemination with the implantation window.
The day of ovulation induction, the investigators will determine progesterone levels. If progesterone\> 1 ng / ml the patient be randomized in one of the following groups:
* Group 1 (intrauterine insemination with sperm donor IAD at 36 hours post-hCG). Cases where the IAD is scheduled at 36 hours post-administration of hCG.
* Group 2 (IAD at 24 hours post-hCG). Cases where the IAD is scheduled at 24 hours post-administration of hCG.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Intrauterine insemination with sperm donor (IAD) at 36 hours post-hCG. Cases where the IAD is scheduled at 36 hours post-administration of hCG.
IAD at 36 hours
Intrauterine insemination with sperm donor at 36 hours post-hCG
Group 2
Intrauterine insemination with sperm donor (IAD) at 24 hours post-hCG. Cases where the IAD is scheduled at 24 hours post-administration of hCG.
IAD at 24 hours
Intrauterine insemination with sperm donor at 24 hours post-hCG
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IAD at 36 hours
Intrauterine insemination with sperm donor at 36 hours post-hCG
IAD at 24 hours
Intrauterine insemination with sperm donor at 24 hours post-hCG
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patent tubes
* Regular cycles (26-35 days)
* FSH levels on day 3 of cycle (\<10 mIU / ml)
* Estradiol levels on day 3 of cycle (\<60 pg / ml)
* Progesterone levels the day of hCG (\> 1 ng / ml)
* Semen donors belonging to the bank of IVI
Exclusion Criteria
* No dominant follicle after two consecutive ultrasound
* Women with P \<1 ng / ml on the day of hCG
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vida Recoletas Sevilla
OTHER
IVI Vigo
OTHER
IVI Madrid
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Antonio Requena
PhD MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Antonio Requena, PhD, MD
Role: PRINCIPAL_INVESTIGATOR
IVI Madrid
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Venetis CA, Kolibianakis EM, Papanikolaou E, Bontis J, Devroey P, Tarlatzis BC. Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. Hum Reprod Update. 2007 Jul-Aug;13(4):343-55. doi: 10.1093/humupd/dmm007. Epub 2007 Apr 3.
Antaki R, Dean NL, Lapensee L, Racicot MH, Menard S, Kadoch IJ. An algorithm combining ultrasound monitoring and urinary luteinizing hormone testing: a novel approach for intrauterine insemination timing. J Obstet Gynaecol Can. 2011 Dec;33(12):1248-52. doi: 10.1016/s1701-2163(16)35110-6.
Azem F, Tal G, Lessing JB, Malcov M, Ben-Yosef D, Almog B, Amit A. Does high serum progesterone level on the day of human chorionic gonadotropin administration affect pregnancy rate after intracytoplasmic sperm injection and embryo transfer? Gynecol Endocrinol. 2008 Jul;24(7):368-72. doi: 10.1080/09513590802196353.
Blockeel C, Knez J, Polyzos NP, De Vos M, Camus M, Tournaye H. Should an intrauterine insemination with donor semen be performed 1 or 2 days after the spontaneous LH rise? A prospective RCT. Hum Reprod. 2014 Apr;29(4):697-703. doi: 10.1093/humrep/deu022. Epub 2014 Feb 18.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1504-MAD-021-AR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.